Expert_review_nihms-468012

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

May 20, 2013

Off

Share This

Adjuvance’s co-founding scientists review the application of natural and synthetic QS-21 in cancer vaccinology.

Related Posts

fochesato_AS01_HuVac

Comparative preclinical evaluation of AS01 versus other Adjuvant systems in a candidate herpes zoster glycoprotein E subunit vaccine

Hz_su_NEJM_nejmoa150118

NEJM Reports Efficacy of QS-21 Containing Herpes Zoster Subunit Vaccine

leroux-roels_1-s2.0-S0264410X14014698-main

Vaccine Adjuvant Systems containing monophosphoryl lipid A andQS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

tejada_bioorg

Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol

Copyright 2009-2016. All rights reserved.